Literature DB >> 16210561

Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia.

Takahiro Sasaki1, Satoshi Iwata, Hirotaka James Okano, Yasuyo Urasaki, Junichi Hamada, Hirotoshi Tanaka, Nam H Dang, Hideyuki Okano, Chikao Morimoto.   

Abstract

BACKGROUND AND
PURPOSE: Some proteins involved in self-repair after stroke in the adult brain are primarily expressed during embryonic development and strongly down-regulated during the early postnatal phase. Neuronal precursor cell-expressed, developmentally down-regulated gene (Nedd) 9 was recognized to be identical to Crk-associated substrate lymphocyte type (Cas-L), a docking protein that associates with a variety of signaling molecules, such as focal adhesion kinase (FAK), proline-rich tyrosine kinase 2 (Pyk2), and Crk. We investigated the involvement of these proteins in the pathophysiology of global cerebral ischemia.
METHODS: The mouse Cas-L/Nedd9 cDNAs were cloned. The expression and function of Cas-L/Nedd9 protein in the pathogenesis of global ischemia in rats was investigated by RT-PCR, Western blot analysis, and immunohistochemistry. The neurite outgrowth of the transfectants of Nedd9 deletion mutants in PC-12 cells was also assessed to clarify the function of the Nedd9 protein.
RESULTS: Nedd9 was a splicing variant of Cas-L and was selectively induced in neurons of the cerebral cortex and hippocampus 1 to 14 days after the ischemia. Induced Nedd9 protein was tyrosine phosphorylated and was bound to FAK in dendrite and soma of neurons after the ischemia. Finally, it was demonstrated that Nedd9 promoted neurite outgrowth of PC-12 cells.
CONCLUSIONS: Our study may support the potential of Nedd9 for participation in the differentiation of neurons after global ischemia in rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210561     DOI: 10.1161/01.STR.0000185672.10390.30

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  15 in total

1.  Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.

Authors:  Sun-Hee Kim; Dianren Xia; Sang-Wook Kim; Vijaykumar Holla; David G Menter; Raymond N Dubois
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

2.  Overexpression of Nedd9 is a prognostic marker of human gastric cancer.

Authors:  Qi Zhang; Huiju Wang; Yingyu Ma; Jun Zhang; Xujun He; Jie Ma; Zhong-Sheng Zhao
Journal:  Med Oncol       Date:  2014-06-07       Impact factor: 3.064

Review 3.  Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.

Authors:  Elena Shagisultanova; Anna V Gaponova; Rashid Gabbasov; Emmanuelle Nicolas; Erica A Golemis
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

4.  High expression of HEF1 predicts a poorer prognosis of hepatocellular carcinoma: A retrospective study.

Authors:  Mei Li; Shumei Yan; Muyan Cai; Jiabin Lu; Meifang Zhang; Ping Yang; Rongzhen Luo
Journal:  Mol Clin Oncol       Date:  2015-12-11

Review 5.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

Review 6.  Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.

Authors:  Mahendra Singh; Lauren Cowell; Sachiko Seo; Geraldine O'Neill; Erica Golemis
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

Review 7.  A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.

Authors:  Geraldine M O'Neill; Sachiko Seo; Ilya G Serebriiskii; Stuart R Lessin; Erica A Golemis
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

8.  Epigenetic regulation of BMP7 in the regenerative response to ischemia.

Authors:  Takeshi Marumo; Keiichi Hishikawa; Masahiro Yoshikawa; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2008-03-05       Impact factor: 10.121

9.  Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer.

Authors:  Si-Sen Zhang; Li-Hua Wu; Qing Liu; Kui-Sheng Chen; Xie-Fu Zhang
Journal:  Onco Targets Ther       Date:  2015-03-10       Impact factor: 4.147

10.  ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor.

Authors:  Lori Rink; Michael F Ochs; Yan Zhou; Margaret von Mehren; Andrew K Godwin
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.